Results From First Large Scale Study On Treatment Of Prescription Opioid Addiction

November 11, 2011

People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study, which was the first randomized large scale […]

Read the full article →

Drug Abuse in Teens | Broadcast on Opioid Addiction

November 2, 2011

Drug Abuse in Teens | Review of Opioid Addiction Broadcast  This is a summary of a broadcast on drug abuse in teens. The original broadcast is at the PCSS-B website. It covers the topic of drug abuse (including Oxycontin) in teens with Rx medications. It also covers drug abuse in teens and the current treatment […]

Read the full article →

Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing

October 27, 2011

Source: Drug and Alcohol Dependence Area: Evidence > Medicines Management > References Background: These studies compared the diversion and injection of buprenorphine-naloxone (BNX), buprenorphine (BPN) and methadone (MET) in Australia. Methods: Surveys were conducted with regular injecting drug users (IDUs) (2004-09, N = 881 to 943), opioid substitution treatment (OST) clients (2008, N = 440) […]

Read the full article →

Subutex Information : Is Subutex Being Discontinued?

October 26, 2011

Subutex Information  Subutex is a medication from Reckitt Benckiser. It is an opioid agonist-antagonist and it is used to treat opioid addiction. This medication is used for detoxification from opioid drugs as well as for long-term “maintenance” treatment for those unable to stay clean form opioid drugs. In this way it is similar to methadone […]

Read the full article →

Welcome To The Oxycontin Addiction Treatment Directory

October 20, 2011

Welcome To The Oxycontin Addiction and Oxycontin Treatment Directory  If you are looking for a Oxycontin addiction treatment, feel free to use our free directory to find help near you. Oxycontin addition and opioid addiction can be treated with the medicaton Suboxone. Suboxone doctors has extra training to treat oxycontin addiction and opioid addiction with […]

Read the full article →

Help A Loved One With Oxycontin Drug Dependence

October 14, 2011

Oxycontin Drug Dependence | Getting Help For Those Close To You  Drug Addiction Skip to: Oxycontin Addiction Treatment Center Directory Methadone Clinic Center List Suboxone Doctor Clinic Near You Getting assistance for a friend with oxycontin drug dependence is a hard process. It is easier said than done to confront your friend and converse the […]

Read the full article →

Drug Addiction : How To Get Oxycontin Long-Term Treatment

October 13, 2011

Long-Term Oxycontin Drug Addiction Treatment Drug Addiction Skip to: Oxycontin  Addiction Treatment Center Directory Methadone Clinic  Center List Suboxone Doctor Clinic Near You   Oxycontin drug addiction affects not merely families, but the those near them. Over the last fifteen years, the volume of oxycontin prescriptions has risen dramatically.  The U.S. Government Accountability Office reports […]

Read the full article →

Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing

October 9, 2011

Abstract: Background: These studies compared the diversion and injection of buprenorphine-naloxone (BNX), buprenorphine (BPN) and methadone (MET) in Australia.Methods: Surveys were conducted with regular injecting drug users (IDUs) (2004–2009, N=881–943), opioid substitution treatment (OST) clients (2008, N=440) and authorised OST prescribers (2007, N=291). Key outcome measures include the unsanctioned removal of supervised doses, diversion, injection, […]

Read the full article →

Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients

October 9, 2011

Abstract: Background: This series of studies examines the pharmacokinetic/pharmacodynamic interactions between buprenorphine, an opioid partial agonist increasingly used in treatment of opioid dependence, and rifampin, a medication used as a first line treatment for tuberculosis; or rifabutin, an alternative antituberculosis medication.Methods: Opioid-dependent individuals on stable doses of buprenorphine/naloxone underwent two, 24-h blood sampling studies: (1) […]

Read the full article →

Gender differences in pharmacokinetics of maintenance dosed buprenorphine

October 9, 2011

Conclusions: Gender-related differences exist in the pharmacokinetics of buprenorphine; differences in body composition appear to have a major impact; differences in CYPA-dependent metabolism may also contribute. (Source: Drug and Alcohol Dependence) MedWorm Sponsor Message: Please support the DoctorsInChains.org campaign for the health workers in Bahrain. #FreeDoctors

Read the full article →

← Previous Entries

Next Entries →